Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation

Mukta Arora, Stephanie J. Lee, Stephen R. Spellman, Daniel J. Weisdorf, Weihua Guan, Mike Haagenson, Tao Wang, Mary H. Horowitz, Michael R. Verneris, Katharina Fleischhauer, Katharine Hsu, Bharat Thyagarajan

Research output: Contribution to journalLetterpeer-review

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)1531-1532
Number of pages2
JournalBiology of Blood and Marrow Transplantation
Issue number8
StatePublished - Aug 1 2016

Bibliographical note

Funding Information:
The CIBMTR is supported by Public Health Service Grant/Cooperative Agreement 5U24-CA076518 from the National Cancer Institute (NCI) , the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID) ; a Grant/Cooperative Agreement 5U10HL069294 from NHLBI and NCI ; a contract HHSH250201200016C with Health Resources and Services Administration (HRSA/DHHS) ; two grants N00014-15-1-0848 and N00014-16-1-2020 from the Office of Naval Research ; and grants from Alexion ; *Amgen, Inc. ; Anonymous donation to the Medical College of Wisconsin ; Astellas Pharma US ; AstraZeneca ; Be the Match Foundation ; ∗Bluebird Bio, Inc. ; ∗Bristol Myers Squibb Oncology ; ∗Celgene Corporation ; Cellular Dynamics International, Inc. ; ∗Chimerix, Inc. ; Fred Hutchinson Cancer Research Center ; Gamida Cell Ltd. ; Genentech, Inc. ; Genzyme Corporation ; ∗Gilead Sciences, Inc. ; Health Research, Inc. Roswell Park Cancer Institute ; HistoGenetics, Inc. ; Incyte Corporation ; Janssen Scientific Affairs, LLC ; ∗Jazz Pharmaceuticals, Inc. ; Jeff Gordon Children's Foundation ; The Leukemia & Lymphoma Society ; Medac, GmbH ; MedImmune ; The Medical College of Wisconsin ; ∗Merck & Co, Inc. ; Mesoblast ; MesoScale Diagnostics, Inc. ; ∗Miltenyi Biotec, Inc. ; National Marrow Donor Program ; Neovii Biotech NA, Inc. ; Novartis Pharmaceuticals Corporation ; Onyx Pharmaceuticals ; Optum Healthcare Solutions, Inc. ; Otsuka America Pharmaceutical, Inc. ; Otsuka Pharmaceutical Co, Ltd. – Japan ; PCORI ; Perkin Elmer, Inc. ; Pfizer, Inc ; ∗Sanofi US ; ∗Seattle Genetics ; ∗Spectrum Pharmaceuticals, Inc. ; St. Baldrick's Foundation ; ∗Sunesis Pharmaceuticals, Inc. ; Swedish Orphan Biovitrum, Inc. ; Takeda Oncology ; Telomere Diagnostics, Inc. ; University of Minnesota ; and ∗Wellpoint, Inc .

Cite this